KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Treasury Shares (2024 - 2025)

Xenon Pharmaceuticals (XENE) has disclosed Treasury Shares for 2 consecutive years, with $348994.0 as the latest value for Q4 2025.

  • On a quarterly basis, Treasury Shares rose 66.19% to $348994.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $348994.0, a 66.19% increase, with the full-year FY2025 number at $348994.0, up 66.19% from a year prior.
  • Treasury Shares was $348994.0 for Q4 2025 at Xenon Pharmaceuticals, up from $313382.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $348994.0 in Q4 2025 to a low of $192000.0 in Q1 2024.